Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9228526rdf:typepubmed:Citationlld:pubmed
pubmed-article:9228526lifeskim:mentionsumls-concept:C1179435lld:lifeskim
pubmed-article:9228526lifeskim:mentionsumls-concept:C0085862lld:lifeskim
pubmed-article:9228526lifeskim:mentionsumls-concept:C1299583lld:lifeskim
pubmed-article:9228526lifeskim:mentionsumls-concept:C1136140lld:lifeskim
pubmed-article:9228526lifeskim:mentionsumls-concept:C0439064lld:lifeskim
pubmed-article:9228526lifeskim:mentionsumls-concept:C0376315lld:lifeskim
pubmed-article:9228526lifeskim:mentionsumls-concept:C1705248lld:lifeskim
pubmed-article:9228526lifeskim:mentionsumls-concept:C1608386lld:lifeskim
pubmed-article:9228526lifeskim:mentionsumls-concept:C1548799lld:lifeskim
pubmed-article:9228526lifeskim:mentionsumls-concept:C1549571lld:lifeskim
pubmed-article:9228526lifeskim:mentionsumls-concept:C1524073lld:lifeskim
pubmed-article:9228526lifeskim:mentionsumls-concept:C0449432lld:lifeskim
pubmed-article:9228526pubmed:issue3lld:pubmed
pubmed-article:9228526pubmed:dateCreated1997-9-9lld:pubmed
pubmed-article:9228526pubmed:abstractTextLong-term depression (LTD) of synaptic strength is induced by glutamate-triggered increases in postsynaptic [Ca2+], through either influx or release from intracellular stores. Induction of LTD has also been reported to require release of Ca2+ from presynaptic stores and activation of presynaptic Ca2+/calmodulin-dependent protein kinase II. This finding leads to the hypothesis that the intercellular messenger nitric oxide (NO) may be a means by which postsynaptic Ca2+ triggers changes expressing LTD in presynaptic terminals. We report that bath application of the oxadiazoloquinoxalone derivative ODQ (4 microM), a selective inhibitor of NO-sensitive guanylyl cyclase (NOGC), markedly attenuated (90%) the magnitude of LTD induced by low-frequency stimulation (LFS; 1 Hz/15 min) of Schaffer collateral-CA1 synapses in hippocampal slices in vitro. Both the NO donor S-nitroso-N-acetylpenicillamine (100 microM) and the membrane-permeant cyclic guanine 3',5'-monophosphate (cGMP) analogue 8-(-4-chlorophenylthio) guanosine (8-pCPT)-cGMP (50 microM) enhanced the magnitude of LTD, which is consistent with he hypothesis that activation of NOGC plays a role in the induction of LTD. Nicotinamide (20 mM), an inhibitor of NO-activated ADP ribosyltransferase, did not impair the induction of LTD. In contrast to de novo LTD, the reversal of long-term potentiation by LFS (depotentiation) was only partially blocked (55%) by ODQ, and heterosynaptic LTD was not impaired at all, suggesting that there are both NOGC-dependent and -independent forms of LTD. Because postsynaptic intracellular infusion of ODQ (500 microM) failed to block the induction of LTD, we conclude that activation of presynaptic NOGC is a necessary step in the induction of an NOGC-dependent component of LTD.lld:pubmed
pubmed-article:9228526pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9228526pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9228526pubmed:languageenglld:pubmed
pubmed-article:9228526pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9228526pubmed:citationSubsetIMlld:pubmed
pubmed-article:9228526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9228526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9228526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9228526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9228526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9228526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9228526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9228526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9228526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9228526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9228526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9228526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9228526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9228526pubmed:statusMEDLINElld:pubmed
pubmed-article:9228526pubmed:issn1050-9631lld:pubmed
pubmed-article:9228526pubmed:authorpubmed-author:ReyesMMlld:pubmed
pubmed-article:9228526pubmed:authorpubmed-author:StantonP KPKlld:pubmed
pubmed-article:9228526pubmed:authorpubmed-author:GageA TATlld:pubmed
pubmed-article:9228526pubmed:issnTypePrintlld:pubmed
pubmed-article:9228526pubmed:volume7lld:pubmed
pubmed-article:9228526pubmed:ownerNLMlld:pubmed
pubmed-article:9228526pubmed:authorsCompleteYlld:pubmed
pubmed-article:9228526pubmed:pagination286-95lld:pubmed
pubmed-article:9228526pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:meshHeadingpubmed-meshheading:9228526-...lld:pubmed
pubmed-article:9228526pubmed:year1997lld:pubmed
pubmed-article:9228526pubmed:articleTitleNitric-oxide-guanylyl-cyclase-dependent and -independent components of multiple forms of long-term synaptic depression.lld:pubmed
pubmed-article:9228526pubmed:affiliationDepartment of Neuroscience, Albert Einstein College of Medicine, Bronx, New York 10461-1602, USA.lld:pubmed
pubmed-article:9228526pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9228526pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9228526pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:9228526pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9228526lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9228526lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9228526lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9228526lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9228526lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9228526lld:pubmed